高龄急性轻型缺血性卒中早期阿替普酶静脉溶栓疗效观察 Observation of the Effect of Alteplase Intravenous Thrombolysis in the Early Stage of Acute Mild Ischemic Stroke in the Elderly
目的 探讨高龄轻型缺血性卒中3 h内行阿替普酶静脉溶栓治疗的疗效及安全性。 方法 将我院2015年10月-2017年10月连续收治入院的发病3 h内48例高龄急性轻型缺血性卒中患者 随机分为阿替普酶静脉溶栓组24例和未溶栓组24例。比较两组患者入院时的一般情况，基线美国 国立卫生研究院卒中量表（National Institutes of Health Stroke Scale，NHISS）评分，治疗24 h后颅内出 血转化率，治疗后90 d改良Rankin量表（modified Rankin Scale，mRS）评分及90 d病死率。 结果 阿替普酶静脉溶栓组和未溶栓组患者一般临床资料、基线...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Editorial Department of Chinese Journal of Stroke
2018-04-01
|
| Series: | Zhongguo cuzhong zazhi |
| Subjects: | |
| Online Access: | http://www.chinastroke.org.cn/CN/article/openArticlePDF.jsp?id=2447 |
| _version_ | 1798042228925399040 |
|---|---|
| author | 杨江胜，朱祖福，高志强，陆强彬，周国庆，方琪 |
| author_facet | 杨江胜，朱祖福，高志强，陆强彬，周国庆，方琪 |
| author_sort | 杨江胜，朱祖福，高志强，陆强彬，周国庆，方琪 |
| collection | DOAJ |
| description | 目的 探讨高龄轻型缺血性卒中3 h内行阿替普酶静脉溶栓治疗的疗效及安全性。 方法 将我院2015年10月-2017年10月连续收治入院的发病3 h内48例高龄急性轻型缺血性卒中患者 随机分为阿替普酶静脉溶栓组24例和未溶栓组24例。比较两组患者入院时的一般情况，基线美国 国立卫生研究院卒中量表（National Institutes of Health Stroke Scale，NHISS）评分，治疗24 h后颅内出 血转化率，治疗后90 d改良Rankin量表（modified Rankin Scale，mRS）评分及90 d病死率。 结果 阿替普酶静脉溶栓组和未溶栓组患者一般临床资料、基线NIHSS评分比较，差异无统计学意 义。阿替普酶静脉溶栓组和未溶栓组治疗24 h后颅内出血转化率分别为4.17%和0（P =1.000），两组 90 d病死率均为4.17%（P =1.000），阿替普酶静脉溶栓组及未溶栓组90 d mRS评分为0～2分的比率 分别为83.33%和54.17%（P =0.029）。 结论 早期阿替普酶静脉溶栓治疗高龄急性轻型缺血性卒中不增加急性期颅内出血转化的风险， 可以改善高龄轻型缺血性卒中患者预后，不增加病死率。
Abstract:
Objective To investigate the efficacy and safety of alteplase intravenous thrombolytic therapy within 3 hours after onset of mild ischemic stroke in the elderly. Methods In our hospital from October 2015 to October 2017, 48 elderly patients with acute mild ischemic stroke who were admitted into our hospital consecutively within 3 hours after onset were randomly divided into two groups: 24 patients in the intravenous thrombolysis group and 24 patients in the non-thrombolysis group. The general condition, baseline National Institute of Health Stroke Scale (NHISS) scores, intracranial hemorrhage conversion rates after 24 hours of treatment, modified Rankin Scale (mRS) score after 90 days of treatment, and 90-day mortality were compared between the two groups on admission. Results There were no significant difference in general clinical data and baseline NIHSS score between the intravenous thrombolytic group and the non-thrombolysis group. In the intravenous thrombolytic group and the non-thrombolysis group, the conversion rate of intracranial hemorrhage after 24 hours was 4.17% and 0 (P =1.000). The 90-day mortality of two groups was 4.17% (P =1.000). The ratio of 90-day mRS score of 0-2 in the intravenous thrombolytic group and the non-thrombolysis group was 83.33% and 54.17% (P =0.029). Conclusion Early alteplase intravenous thrombolysis in elderly patients with acute ischemic stroke does not increase the risk of acute intracranial hemorrhage, it can significantly improve the prognosis of elderly patients with mild ischemic stroke, without increasing the mortality. |
| first_indexed | 2024-04-11T22:32:35Z |
| format | Article |
| id | doaj.art-0190e6d9df88430eaa18d2ccfd2fd5a0 |
| institution | Directory Open Access Journal |
| issn | 1673-5765 |
| language | zho |
| last_indexed | 2024-04-11T22:32:35Z |
| publishDate | 2018-04-01 |
| publisher | Editorial Department of Chinese Journal of Stroke |
| record_format | Article |
| series | Zhongguo cuzhong zazhi |
| spelling | doaj.art-0190e6d9df88430eaa18d2ccfd2fd5a02022-12-22T03:59:18ZzhoEditorial Department of Chinese Journal of StrokeZhongguo cuzhong zazhi1673-57652018-04-0113431732110.3969/j.issn.1673-5765.2018.04.005高龄急性轻型缺血性卒中早期阿替普酶静脉溶栓疗效观察 Observation of the Effect of Alteplase Intravenous Thrombolysis in the Early Stage of Acute Mild Ischemic Stroke in the Elderly杨江胜，朱祖福，高志强，陆强彬，周国庆，方琪 0方琪 yjs990115@hotmail.com目的 探讨高龄轻型缺血性卒中3 h内行阿替普酶静脉溶栓治疗的疗效及安全性。 方法 将我院2015年10月-2017年10月连续收治入院的发病3 h内48例高龄急性轻型缺血性卒中患者 随机分为阿替普酶静脉溶栓组24例和未溶栓组24例。比较两组患者入院时的一般情况，基线美国 国立卫生研究院卒中量表（National Institutes of Health Stroke Scale，NHISS）评分，治疗24 h后颅内出 血转化率，治疗后90 d改良Rankin量表（modified Rankin Scale，mRS）评分及90 d病死率。 结果 阿替普酶静脉溶栓组和未溶栓组患者一般临床资料、基线NIHSS评分比较，差异无统计学意 义。阿替普酶静脉溶栓组和未溶栓组治疗24 h后颅内出血转化率分别为4.17%和0（P =1.000），两组 90 d病死率均为4.17%（P =1.000），阿替普酶静脉溶栓组及未溶栓组90 d mRS评分为0～2分的比率 分别为83.33%和54.17%（P =0.029）。 结论 早期阿替普酶静脉溶栓治疗高龄急性轻型缺血性卒中不增加急性期颅内出血转化的风险， 可以改善高龄轻型缺血性卒中患者预后，不增加病死率。 Abstract: Objective To investigate the efficacy and safety of alteplase intravenous thrombolytic therapy within 3 hours after onset of mild ischemic stroke in the elderly. Methods In our hospital from October 2015 to October 2017, 48 elderly patients with acute mild ischemic stroke who were admitted into our hospital consecutively within 3 hours after onset were randomly divided into two groups: 24 patients in the intravenous thrombolysis group and 24 patients in the non-thrombolysis group. The general condition, baseline National Institute of Health Stroke Scale (NHISS) scores, intracranial hemorrhage conversion rates after 24 hours of treatment, modified Rankin Scale (mRS) score after 90 days of treatment, and 90-day mortality were compared between the two groups on admission. Results There were no significant difference in general clinical data and baseline NIHSS score between the intravenous thrombolytic group and the non-thrombolysis group. In the intravenous thrombolytic group and the non-thrombolysis group, the conversion rate of intracranial hemorrhage after 24 hours was 4.17% and 0 (P =1.000). The 90-day mortality of two groups was 4.17% (P =1.000). The ratio of 90-day mRS score of 0-2 in the intravenous thrombolytic group and the non-thrombolysis group was 83.33% and 54.17% (P =0.029). Conclusion Early alteplase intravenous thrombolysis in elderly patients with acute ischemic stroke does not increase the risk of acute intracranial hemorrhage, it can significantly improve the prognosis of elderly patients with mild ischemic stroke, without increasing the mortality.http://www.chinastroke.org.cn/CN/article/openArticlePDF.jsp?id=2447急性轻型缺血性卒中静脉溶栓阿替普酶acute mild ischemic strokeintravenous thrombolysisalteplase |
| spellingShingle | 杨江胜，朱祖福，高志强，陆强彬，周国庆，方琪 高龄急性轻型缺血性卒中早期阿替普酶静脉溶栓疗效观察 Observation of the Effect of Alteplase Intravenous Thrombolysis in the Early Stage of Acute Mild Ischemic Stroke in the Elderly Zhongguo cuzhong zazhi 急性轻型缺血性卒中 静脉溶栓 阿替普酶 acute mild ischemic stroke intravenous thrombolysis alteplase |
| title | 高龄急性轻型缺血性卒中早期阿替普酶静脉溶栓疗效观察 Observation of the Effect of Alteplase Intravenous Thrombolysis in the Early Stage of Acute Mild Ischemic Stroke in the Elderly |
| title_full | 高龄急性轻型缺血性卒中早期阿替普酶静脉溶栓疗效观察 Observation of the Effect of Alteplase Intravenous Thrombolysis in the Early Stage of Acute Mild Ischemic Stroke in the Elderly |
| title_fullStr | 高龄急性轻型缺血性卒中早期阿替普酶静脉溶栓疗效观察 Observation of the Effect of Alteplase Intravenous Thrombolysis in the Early Stage of Acute Mild Ischemic Stroke in the Elderly |
| title_full_unstemmed | 高龄急性轻型缺血性卒中早期阿替普酶静脉溶栓疗效观察 Observation of the Effect of Alteplase Intravenous Thrombolysis in the Early Stage of Acute Mild Ischemic Stroke in the Elderly |
| title_short | 高龄急性轻型缺血性卒中早期阿替普酶静脉溶栓疗效观察 Observation of the Effect of Alteplase Intravenous Thrombolysis in the Early Stage of Acute Mild Ischemic Stroke in the Elderly |
| title_sort | 高龄急性轻型缺血性卒中早期阿替普酶静脉溶栓疗效观察 observation of the effect of alteplase intravenous thrombolysis in the early stage of acute mild ischemic stroke in the elderly |
| topic | 急性轻型缺血性卒中 静脉溶栓 阿替普酶 acute mild ischemic stroke intravenous thrombolysis alteplase |
| url | http://www.chinastroke.org.cn/CN/article/openArticlePDF.jsp?id=2447 |
| work_keys_str_mv | AT yángjiāngshèngzhūzǔfúgāozhìqiánglùqiángbīnzhōuguóqìngfāngqí gāolíngjíxìngqīngxíngquēxuèxìngzúzhōngzǎoqīātìpǔméijìngmàiróngshuānliáoxiàoguāncháobservationoftheeffectofalteplaseintravenousthrombolysisintheearlystageofacutemildischemicstrokeintheelderly |